Economic impact of cardiovascular co-morbidity in patients with type-2 diabetes

被引：0
|
作者：
Mody, R
Kalsekar, I
Kavookjian, J
Iyer, S
Rajagopalan, R
Pawar, V
机构：
[1] W Virginia Univ, Morgantown, WV 26506 USA
[2] Butler Univ, Indianapolis, IN 46208 USA
[3] Takeda Pharmaceut N Amer Inc, Lincolnshire, IL USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62957-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：359 / 359
页数：1
相关论文
共 50 条
  • [1] Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes
    Mody, Reema
    Kalsekar, Iftekhar
    Kavookjian, Jan
    Iyer, Shrividya
    Rajagopalan, Rukmini
    Pawar, Vivek
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (02) : 75 - 83
  • [2] The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes
    Diethelm Tschöpe
    Markolf Hanefeld
    Juris J Meier
    Anselm K Gitt
    Martin Halle
    Peter Bramlage
    Petra-Maria Schumm-Draeger
    [J]. Cardiovascular Diabetology, 12
  • [3] The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes
    Tschoepe, Diethelm
    Hanefeld, Markolf
    Meier, Juris J.
    Gitt, Anselm K.
    Halle, Martin
    Bramlage, Peter
    Schumm-Draeger, Petra-Maria
    [J]. CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [4] Economic impact of cardiovascular events in newly diagnosed type-2 diabetes patients
    Rajagopalan, R
    Iyer, S
    Carlson, A
    Friedman, F
    Morris, LS
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 249 - 249
  • [5] Type-2 diabetes, a co-morbidity in Covid-19: does insulin signaling matter?
    Mishra, Devanshi
    Dey, Chinmoy Sankar
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2021, 49 (02) : 987 - 995
  • [6] Non-cardiovascular co-morbidity in elderly patients with heart failure outnumbers cardiovascular co-morbidity
    van der Wel, Mark C.
    Jansen, Rene W. M. M.
    Bakx, J. Carel
    Bor, Hans H. J.
    OldeRikkert, Marcel G. M.
    van Weel, Chris
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (6-7) : 709 - 715
  • [7] Cardiovascular Co-Morbidity
    不详
    [J]. UNFALLCHIRURG, 2011, 114 (08): : 653 - 653
  • [8] Perceived challenges and priorities in co-morbidity management of older patients with Type 2 diabetes
    Beverly, E. A.
    Wray, L. A.
    Chiu, C. J.
    Weinger, K.
    [J]. DIABETIC MEDICINE, 2011, 28 (07) : 781 - 784
  • [9] Cardiovascular co-morbidity in patients with rheumatic diseases
    Frostegard, Johan
    [J]. ARTHRITIS RESEARCH & THERAPY, 2011, 13 (03)
  • [10] Cardiovascular co-morbidity in patients with rheumatic diseases
    Johan Frostegård
    [J]. Arthritis Research & Therapy, 13
12345